CV-01 (Cureverse)

N/A

Report date: 2025/01/20 16:51:50
NMEFirst In Class

Base Information

Drug NameCV-01 (Cureverse)
Drug Alias NameCV-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 stimulantsKelch-like ECH-associated protein 1 modulators
TargetsNuclear factor erythroid 2-related factor 2Kelch-like ECH-associated protein 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCureverse Inc
China Registration ClassN/A

Develop Information

Active CompaniesAngelini PharmaCureverse Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A